Evidence map›Paper›PMID 24491510›Full record

ArticleBiomaterials2014

A porous tissue engineering scaffold selectively degraded by cell-generated reactive oxygen species.

John R Martin, Mukesh K Gupta, Jonathan M Page, Fang Yu, Jeffrey M Davidson, Scott A Guelcher, Craig L Duvall

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John R MartinBiomedical Engineering, Vanderbilt University, 5824 Stevenson Center, PMB 351631, Nashville, TN 37235-1631, USA.
Mukesh K GuptaBiomedical Engineering, Vanderbilt University, 5824 Stevenson Center, PMB 351631, Nashville, TN 37235-1631, USA.
Jonathan M PageChemical and Biomolecular Engineering, Vanderbilt University, 2301 Vanderbilt Place, VU Station B #351604, Nashville, TN 37235-1604, USA.
Fang YuDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Jeffrey M DavidsonDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Medical Research Service, Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN 37212, USA.
Scott A GuelcherChemical and Biomolecular Engineering, Vanderbilt University, 2301 Vanderbilt Place, VU Station B #351604, Nashville, TN 37235-1604, USA.
Craig L DuvallBiomedical Engineering, Vanderbilt University, 5824 Stevenson Center, PMB 351631, Nashville, TN 37235-1631, USA. Electronic address: craig.duvall@vanderbilt.edu.

Funding

Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Skin Regeneration with Stem Cells and ScaffoldsR01AR056138 · NIAMS · VANDERBILT UNIVERSITY · PI DAVIDSON, JEFFREY M., GUELCHER, SCOTT A · 2009 to 2013
$3.3M
Injectable Scaffold for Efficient, Tunable siRNA Delivery to Skin WoundsR21EB012750 · NIBIB · VANDERBILT UNIVERSITY · PI DUVALL, CRAIG LEWIS · 2011 to 2012
$418k
NIAMS NIH HHS R01 AR056138NIAMS NIH HHS R01AR056138NIBIB NIH HHS R21 EB012750NIBIB NIH HHS R21EB012750NIDDK NIH HHS T32 DK101003
6 · The paper itself

Abstract

Biodegradable tissue engineering scaffolds are commonly fabricated from poly(lactide-co-glycolide) (PLGA) or similar polyesters that degrade by hydrolysis. PLGA hydrolysis generates acidic breakdown products that trigger an accelerated, autocatalytic degradation mechanism that can create mismatched rates of biomaterial breakdown and tissue formation. Reactive oxygen species (ROS) are key mediators of cell function in both health and disease, especially at sites of inflammation and tissue healing, and induction of inflammation and ROS are natural components of the in vivo response to biomaterial implantation. Thus, polymeric biomaterials that are selectively degraded by cell-generated ROS may have potential for creating tissue engineering scaffolds with better matched rates of tissue in-growth and cell-mediated scaffold biodegradation. To explore this approach, a series of poly(thioketal) (PTK) urethane (PTK-UR) biomaterial scaffolds were synthesized that degrade specifically by an ROS-dependent mechanism. PTK-UR scaffolds had significantly higher compressive moduli than analogous poly(ester urethane) (PEUR) scaffolds formed from hydrolytically-degradable ester-based diols (p < 0.05). Unlike PEUR scaffolds, the PTK-UR scaffolds were stable under aqueous conditions out to 25 weeks but were selectively degraded by ROS, indicating that their biodegradation would be exclusively cell-mediated. The in vitro oxidative degradation rates of the PTK-URs followed first-order degradation kinetics, were significantly dependent on PTK composition (p < 0.05), and correlated to ROS concentration. In subcutaneous rat wounds, PTK-UR scaffolds supported cellular infiltration and granulation tissue formation, followed first-order degradation kinetics over 7 weeks, and produced significantly greater stenting of subcutaneous wounds compared to PEUR scaffolds. These combined results indicate that ROS-degradable PTK-UR tissue engineering scaffolds have significant advantages over analogous polyester-based biomaterials and provide a robust, cell-degradable substrate for guiding new tissue formation.

Indexed as

Tissue EngineeringTissue ScaffoldsAnimalsBiocompatible MaterialsCatalysisLactic AcidMicroscopy, Electron, ScanningPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPorosityRatsReactive Oxygen SpeciesWounds and InjuriesBiocompatible MaterialsLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerReactive Oxygen SpeciesBiodegradationMacrophageOxidationPolyurethaneScaffoldWound healing

Identifiers

PMID24491510
PMCPMC3975079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.